Copyright Reports & Markets. All rights reserved.

Global Leishmaniasis Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Leishmaniasis Treatment
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Leishmaniasis Treatment by Type
    • 1.3.1 Overview: Global Leishmaniasis Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Leishmaniasis Treatment Consumption Value Market Share by Type in 2023
    • 1.3.3 Meglumine Antimoniate
    • 1.3.4 Pentamidine
    • 1.3.5 Hydroxyl Amidine Stilbene
    • 1.3.6 Amphotericin B
  • 1.4 Global Leishmaniasis Treatment Market by Application
    • 1.4.1 Overview: Global Leishmaniasis Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Visceral Leishmaniasis
    • 1.4.3 Cutaneous Leishmaniasis
  • 1.5 Global Leishmaniasis Treatment Market Size & Forecast
  • 1.6 Global Leishmaniasis Treatment Market Size and Forecast by Region
    • 1.6.1 Global Leishmaniasis Treatment Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Leishmaniasis Treatment Market Size by Region, (2019-2030)
    • 1.6.3 North America Leishmaniasis Treatment Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Leishmaniasis Treatment Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Leishmaniasis Treatment Market Size and Prospect (2019-2030)
    • 1.6.6 South America Leishmaniasis Treatment Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Leishmaniasis Treatment Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Merck
    • 2.1.1 Merck Details
    • 2.1.2 Merck Major Business
    • 2.1.3 Merck Leishmaniasis Treatment Product and Solutions
    • 2.1.4 Merck Leishmaniasis Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Merck Recent Developments and Future Plans
  • 2.2 iCo Therapeutics
    • 2.2.1 iCo Therapeutics Details
    • 2.2.2 iCo Therapeutics Major Business
    • 2.2.3 iCo Therapeutics Leishmaniasis Treatment Product and Solutions
    • 2.2.4 iCo Therapeutics Leishmaniasis Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 iCo Therapeutics Recent Developments and Future Plans
  • 2.3 AEterna Zentaris
    • 2.3.1 AEterna Zentaris Details
    • 2.3.2 AEterna Zentaris Major Business
    • 2.3.3 AEterna Zentaris Leishmaniasis Treatment Product and Solutions
    • 2.3.4 AEterna Zentaris Leishmaniasis Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 AEterna Zentaris Recent Developments and Future Plans
  • 2.4 AEterna Zentaris AG
    • 2.4.1 AEterna Zentaris AG Details
    • 2.4.2 AEterna Zentaris AG Major Business
    • 2.4.3 AEterna Zentaris AG Leishmaniasis Treatment Product and Solutions
    • 2.4.4 AEterna Zentaris AG Leishmaniasis Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 AEterna Zentaris AG Recent Developments and Future Plans
  • 2.5 Eurofins Advinus
    • 2.5.1 Eurofins Advinus Details
    • 2.5.2 Eurofins Advinus Major Business
    • 2.5.3 Eurofins Advinus Leishmaniasis Treatment Product and Solutions
    • 2.5.4 Eurofins Advinus Leishmaniasis Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Eurofins Advinus Recent Developments and Future Plans
  • 2.6 Pieris Pharmaceuticals
    • 2.6.1 Pieris Pharmaceuticals Details
    • 2.6.2 Pieris Pharmaceuticals Major Business
    • 2.6.3 Pieris Pharmaceuticals Leishmaniasis Treatment Product and Solutions
    • 2.6.4 Pieris Pharmaceuticals Leishmaniasis Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Pieris Pharmaceuticals Recent Developments and Future Plans
  • 2.7 Dafra Pharma
    • 2.7.1 Dafra Pharma Details
    • 2.7.2 Dafra Pharma Major Business
    • 2.7.3 Dafra Pharma Leishmaniasis Treatment Product and Solutions
    • 2.7.4 Dafra Pharma Leishmaniasis Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Dafra Pharma Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Leishmaniasis Treatment Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Leishmaniasis Treatment by Company Revenue
    • 3.2.2 Top 3 Leishmaniasis Treatment Players Market Share in 2023
    • 3.2.3 Top 6 Leishmaniasis Treatment Players Market Share in 2023
  • 3.3 Leishmaniasis Treatment Market: Overall Company Footprint Analysis
    • 3.3.1 Leishmaniasis Treatment Market: Region Footprint
    • 3.3.2 Leishmaniasis Treatment Market: Company Product Type Footprint
    • 3.3.3 Leishmaniasis Treatment Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Leishmaniasis Treatment Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Leishmaniasis Treatment Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Leishmaniasis Treatment Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Leishmaniasis Treatment Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Leishmaniasis Treatment Consumption Value by Type (2019-2030)
  • 6.2 North America Leishmaniasis Treatment Consumption Value by Application (2019-2030)
  • 6.3 North America Leishmaniasis Treatment Market Size by Country
    • 6.3.1 North America Leishmaniasis Treatment Consumption Value by Country (2019-2030)
    • 6.3.2 United States Leishmaniasis Treatment Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Leishmaniasis Treatment Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Leishmaniasis Treatment Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Leishmaniasis Treatment Consumption Value by Type (2019-2030)
  • 7.2 Europe Leishmaniasis Treatment Consumption Value by Application (2019-2030)
  • 7.3 Europe Leishmaniasis Treatment Market Size by Country
    • 7.3.1 Europe Leishmaniasis Treatment Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Leishmaniasis Treatment Market Size and Forecast (2019-2030)
    • 7.3.3 France Leishmaniasis Treatment Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Leishmaniasis Treatment Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Leishmaniasis Treatment Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Leishmaniasis Treatment Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Leishmaniasis Treatment Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Leishmaniasis Treatment Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Leishmaniasis Treatment Market Size by Region
    • 8.3.1 Asia-Pacific Leishmaniasis Treatment Consumption Value by Region (2019-2030)
    • 8.3.2 China Leishmaniasis Treatment Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Leishmaniasis Treatment Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Leishmaniasis Treatment Market Size and Forecast (2019-2030)
    • 8.3.5 India Leishmaniasis Treatment Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Leishmaniasis Treatment Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Leishmaniasis Treatment Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Leishmaniasis Treatment Consumption Value by Type (2019-2030)
  • 9.2 South America Leishmaniasis Treatment Consumption Value by Application (2019-2030)
  • 9.3 South America Leishmaniasis Treatment Market Size by Country
    • 9.3.1 South America Leishmaniasis Treatment Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Leishmaniasis Treatment Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Leishmaniasis Treatment Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Leishmaniasis Treatment Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Leishmaniasis Treatment Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Leishmaniasis Treatment Market Size by Country
    • 10.3.1 Middle East & Africa Leishmaniasis Treatment Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Leishmaniasis Treatment Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Leishmaniasis Treatment Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Leishmaniasis Treatment Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Leishmaniasis Treatment Market Drivers
  • 11.2 Leishmaniasis Treatment Market Restraints
  • 11.3 Leishmaniasis Treatment Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Leishmaniasis Treatment Industry Chain
  • 12.2 Leishmaniasis Treatment Upstream Analysis
  • 12.3 Leishmaniasis Treatment Midstream Analysis
  • 12.4 Leishmaniasis Treatment Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Leishmaniasis Treatment market size was valued at USD 97.9 million in 2023 and is forecast to a readjusted size of USD 135.8 million by 2030 with a CAGR of 4.8% during review period.
    A drug used to treat diseases caused by parasitic protozoa leishmania
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    The Global Info Research report includes an overview of the development of the Leishmaniasis Treatment industry chain, the market status of Visceral Leishmaniasis (Meglumine Antimoniate, Pentamidine), Cutaneous Leishmaniasis (Meglumine Antimoniate, Pentamidine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Leishmaniasis Treatment.
    Regionally, the report analyzes the Leishmaniasis Treatment markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Leishmaniasis Treatment market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Leishmaniasis Treatment market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Leishmaniasis Treatment industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Meglumine Antimoniate, Pentamidine).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Leishmaniasis Treatment market.
    Regional Analysis: The report involves examining the Leishmaniasis Treatment market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Leishmaniasis Treatment market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Leishmaniasis Treatment:
    Company Analysis: Report covers individual Leishmaniasis Treatment players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Leishmaniasis Treatment This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Visceral Leishmaniasis, Cutaneous Leishmaniasis).
    Technology Analysis: Report covers specific technologies relevant to Leishmaniasis Treatment. It assesses the current state, advancements, and potential future developments in Leishmaniasis Treatment areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Leishmaniasis Treatment market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Leishmaniasis Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Meglumine Antimoniate
    Pentamidine
    Hydroxyl Amidine Stilbene
    Amphotericin B
    Market segment by Application
    Visceral Leishmaniasis
    Cutaneous Leishmaniasis
    Market segment by players, this report covers
    Merck
    iCo Therapeutics
    AEterna Zentaris
    AEterna Zentaris AG
    Eurofins Advinus
    Pieris Pharmaceuticals
    Dafra Pharma
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Leishmaniasis Treatment product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Leishmaniasis Treatment, with revenue, gross margin and global market share of Leishmaniasis Treatment from 2019 to 2024.
    Chapter 3, the Leishmaniasis Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Leishmaniasis Treatment market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Leishmaniasis Treatment.
    Chapter 13, to describe Leishmaniasis Treatment research findings and conclusion.

    Buy now